Hoppe RT - Search Results

1

Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies).

Mou E, Advani RH, von Eyben R, Rosenberg SA, Hoppe RT. Mou E, et al. Among authors: hoppe rt. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):444-451. doi: 10.1016/j.ijrobp.2020.12.039. Epub 2020 Dec 30. Int J Radiat Oncol Biol Phys. 2021. PMID: 33385495

2

Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.

Hoppe RT, Portlock CS, Glatstein E, Rosenberg SA, Kaplan HS. Hoppe RT, et al. Cancer. 1979 Feb;43(2):472-81. doi: 10.1002/1097-0142(197902)43:2<472::aid-cncr2820430211>3.0.co;2-w. Cancer. 1979. PMID: 369676 Clinical Trial. No abstract available.

3

The management of Hodgkin's disease in relapse after primary radiation therapy.

Hoppe RT. Hoppe RT. Eur J Cancer. 1992;28A(11):1920-2. doi: 10.1016/0959-8049(92)90036-2. Eur J Cancer. 1992. PMID: 1389536 Review.

4

The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease.

Horning SJ, Ang PT, Hoppe RT, Rosenberg SA. Horning SJ, et al. Among authors: hoppe rt. Ann Oncol. 1992 Nov;3(9):747-54. doi: 10.1093/oxfordjournals.annonc.a058333. Ann Oncol. 1992. PMID: 1450064 Free article. Clinical Trial.

5

Combined-modality therapy for the treatment of Hodgkin's disease.

Hoppe RT. Hoppe RT. Front Radiat Ther Oncol. 1992;26:172-80. Front Radiat Ther Oncol. 1992. PMID: 1511919 Review. No abstract available.

6

The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data.

Horning SJ, Chao NJ, Negrin RS, Hoppe RT, Kwak LW, Long GD, Stallbaum B, O'Connor P, Blume KG. Horning SJ, et al. Among authors: hoppe rt. Ann Oncol. 1991 Jan;2 Suppl 1:47-50. doi: 10.1093/annonc/2.suppl_1.47. Ann Oncol. 1991. PMID: 2043498 Free article.

7

Radiation therapy in the management of Hodgkin's disease.

Hoppe RT. Hoppe RT. Semin Oncol. 1990 Dec;17(6):704-15. Semin Oncol. 1990. PMID: 2251517 Review. No abstract available.

8

Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.

Roach M 3rd, Brophy N, Cox R, Varghese A, Hoppe RT. Roach M 3rd, et al. Among authors: hoppe rt. J Clin Oncol. 1990 Apr;8(4):623-9. doi: 10.1200/JCO.1990.8.4.623. J Clin Oncol. 1990. PMID: 2313331

9

Radiation therapy in the management of bulky mediastinal Hodgkin's disease.

Behar RA, Hoppe RT. Behar RA, et al. Among authors: hoppe rt. Cancer. 1990 Jul 1;66(1):75-9. doi: 10.1002/1097-0142(19900701)66:1<75::aid-cncr2820660115>3.0.co;2-z. Cancer. 1990. PMID: 2354412

10

Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease.

Watchie J, Coleman CN, Raffin TA, Cox RS, Raubitschek AA, Fahey T, Hoppe RT, Van Kessel A. Watchie J, et al. Among authors: hoppe rt. Int J Radiat Oncol Biol Phys. 1987 Apr;13(4):517-24. doi: 10.1016/0360-3016(87)90066-6. Int J Radiat Oncol Biol Phys. 1987. PMID: 2435687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters